Peer Review reports
From: ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer
| Original Submission | ||
|---|---|---|
| 16 Oct 2022 | Submitted | Original manuscript |
| 21 Feb 2023 | Reviewed | Reviewer Report |
| 26 Mar 2023 | Reviewed | Reviewer Report |
| 12 Apr 2023 | Author responded | Author comments - Yingying Xu |
| Resubmission - Version 2 | ||
| 12 Apr 2023 | Submitted | Manuscript version 2 |
| 13 Apr 2023 | Author responded | Author comments - Yingying Xu |
| Resubmission - Version 3 | ||
| 13 Apr 2023 | Submitted | Manuscript version 3 |
| 15 Apr 2023 | Author responded | Author comments - Yingying Xu |
| Resubmission - Version 4 | ||
| 15 Apr 2023 | Submitted | Manuscript version 4 |
| 17 Apr 2023 | Author responded | Author comments - Yingying Xu |
| Resubmission - Version 5 | ||
| 17 Apr 2023 | Submitted | Manuscript version 5 |
| 18 Apr 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 29 Apr 2023 | Editorially accepted | |
| 15 May 2023 | Article published | 10.1186/s12885-023-10904-4 |
You can find further information about peer review here.